Thomas Weisel Partners

Following a recent merger with Thomas Weisel Partners, Stifel Financial (NYSE: SF) now has total research coverage of 1,143 companies. The firm has been pursuing an aggressive growth strategy for the past few years, where they sought to grow their coverage base, trading operations, research...

Following the strong quarterly results posted by Apple Inc. (NASDAQ: AAPL) on Tuesday, analysts at three brokerages have raised the price target for Apple Inc. stock today. Barclays Capital has raised its price target for the company from $300 to $315. Deutsche Bank has raised its price target for...

In a report released by Thomas Weisel Partners today, the firm reiterated their Overweight rating on shares of Google (NASDAQ: GOOG) and their $690 price target. The analysts said that they "would add to positions on weakness as we believe investments in key areas of product development are key to...

Analysts at Thomas Weisel Partners reiterate their “overweight” rating on Idenix Pharmaceuticals, Inc (NASDAQ: IDIX). The price target for IDIX is set to $6. According to the research note, Idenix Pharmaceuticals has announced “two additional dose cohorts of data from the Phase IIa trial of IDX184...

After yesterday's market close, CF Industries (NYSE: CF) reported net sales of $502 million in the first quarter of 2010. This number was a modest miss of Thomas Weisel Partners' estimate of $516 million and well below consensus estimates of $560 million. CF also announced that it has commenced a...

Analysts Michael Scialla and Daniel Guffey at Thomas Weisel Partners have raised their 12-month price target for Atlas Energy, Inc. (NASDAQ: ATLS) from $44 to $50. The company has announced that it has entered into a $1.7 billion joint venture with India’s Reliance Industries, whereby it will sell...

Analysts at Thomas Weisel maintain their Overweight rating for Computer Sciences Corporation (NYSE: CSC) despite a report that the company may have missed a milestone regarding its Lorenzo patient administration system. Analysts outlined the situation by stating that, “According to [a] press report...

Analysts Doug Reid and Vivek Manipadam at Thomas Weisel Partners have released an update on EMC Corporation (NYSE: EMC). Analysts have reiterated their Overweight rating for the company following recent industry checks, which suggest that the company is on track to deliver modest upside to EPS in...

Thomas Weisel Partners analysts David Grossman, Melissa Moran and Nicole Conway rated shares of ExlService Holdings, Inc. (Nasdaq: EXLS) Overweight, with a price target of $21. The analysts said that ExlService Holdings gets 55% of its revenue from the largest companies in the insurance market but...

Analysts at Thomas Weisel Partners maintain their "overweight" rating on ViroPharma Incorporated (NASDAQ: VPHM). The target price for VPHM has been raised from $14 to $17. According to Thomas Weisel Partners, the target price has been raised to "reflect the impact of an aggressive and comprehensive...

Thomas Weisel Partners analysts Benjamin Mogil and Benjamin Shapiro maintained their Market Weight rating for shares of Lions Gate Entertainment (NYSE: LGF) and raised the price target from $5 to $6. Although on its own they value Lions Gate Entertainment at $5 to $5.50 per share, the $6 price...

Analyst Jeff Osborne at Thomas Weisel Partners has released an update on Metabolix, Inc. (NASDAQ: MBLX). Thomas Weisel met with the company’s management on Thursday during its Boston area Clean Tech Bus Tour. Management at Metabolix highlighted during the meeting the progress that has been made...